Tazorax 1.125 Injection 1

Tazorax 1.125 Injection 1 is used for:

• Managing complicated intra-abdominal infections

• Controlling complicated urinary tract infections, including pyelonephritis

• Dealing with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia

• Addressing bacterial septicaemia

Here's how you should administer Tazorax 1.125 Injection 1:

• The injection is to be given intravenously, preferably over one hour.

• Make sure a trained healthcare professional administers the injection.

• Before administering, ensure the solution is appropriately diluted with a compatible IV solution.

• After reconstitution, the solution should be used within 24 hours if kept at room temperature or within 7 days if refrigerated.

Tazorax 1.125 Injection 1 is administered intravenously.

Tazorax 1.125 Injection 1 consists of two active ingredients which work in tandem:

• Ceftriaxone (1000 mg): The main function of this ingredient is to damage the wall of the bacteria's cell by binding to certain proteins (penicillin-binding proteins) on the cell's inner membrane. As a result, the peptidoglycan chainsformation is disrupted thus weakening the cell wall's strength and rigidity. This causes cell lysis.

• Tazobactam (125 mg): It protects ceftriaxone from being broken down. Ceftriaxone can be broken down by enzymes (beta-lactamases) produced by resistant bacteria. By attaching itself to these enzymes and rendering them ineffective, tazobactam ensures that ceftriaxone can perform its antibacterial function even against resistant beta-lactamase-producing bacteria.

• Store Tazorax 1.125 Injection 1 in the refrigerator or at 2°C to 8°C.

• Do not freeze this injection.

• Keep the medicine away from direct light and moisture.

• Always keep this medicine out of reach of children.

• Drinking plenty of water can help flush bacteria out of your system.

• Maintain a balanced diet with sufficient fibre to aid digestion and prevent constipation.